{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:39:32Z","timestamp":1791243572664,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NTNU Norwegian University of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00234-026-04133-2","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:11:04Z","timestamp":1786349464000},"page":"2257-2271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["7 Tesla MRI with Quantitative Susceptibility Mapping: qualitative grading and quantitative focal measurements of the substantia nigra as a potential biomarker for Parkinson\u2019s disease"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2020-8717","authenticated-orcid":false,"given":"Runa G.","family":"Unsg\u00e5rd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjersti E.","family":"Stige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Kristoffersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l E.","family":"Goa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Tzoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik M.","family":"Berntsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"11","key":"4133_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","volume":"16","author":"GBDNDC Group","year":"2017","unstructured":"Group GBDNDC (2017) Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 16(11):877\u2013897","journal-title":"Lancet Neurol"},{"issue":"4","key":"4133_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79(4):368\u2013376","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"4133_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40035-023-00378-6","volume":"12","author":"ZD Zhou","year":"2023","unstructured":"Zhou ZD et al (2023) Role of dopamine in the pathophysiology of Parkinson\u2019s disease. Transl Neurodegener 12(1):44","journal-title":"Transl Neurodegener"},{"issue":"9","key":"4133_CR4","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1093\/brain\/awaa216","volume":"143","author":"E Biondetti","year":"2020","unstructured":"Biondetti E et al (2020) Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson\u2019s disease. Brain 143(9):2757\u20132770","journal-title":"Brain"},{"issue":"9","key":"4133_CR5","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/brain\/awaa252","volume":"143","author":"DE Vaillancourt","year":"2020","unstructured":"Vaillancourt DE, Mitchell T (2020) Parkinson\u2019s disease progression in the substantia nigra: location, location, location. Brain 143(9):2628\u20132630","journal-title":"Brain"},{"issue":"1","key":"4133_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41531-021-00185-8","volume":"7","author":"D Bega","year":"2021","unstructured":"Bega D et al (2021) Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis. NPJ Parkinsons Dis 7(1):43","journal-title":"NPJ Parkinsons Dis"},{"issue":"5","key":"4133_CR7","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1007\/s00415-023-11563-y","volume":"270","author":"K Tsang","year":"2023","unstructured":"Tsang K, Walker R (2023) Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study. J Neurol 270(5):2550\u20132558","journal-title":"J Neurol"},{"issue":"6","key":"4133_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1212\/WNL.0b013e31829e6fd2","volume":"81","author":"AI Blazejewska","year":"2013","unstructured":"Blazejewska AI et al (2013) Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology 81(6):534\u2013540","journal-title":"Neurology"},{"issue":"4","key":"4133_CR9","doi-asserted-by":"publisher","first-page":"e93814","DOI":"10.1371\/journal.pone.0093814","volume":"9","author":"ST Schwarz","year":"2014","unstructured":"Schwarz ST et al (2014) The \u2018swallow tail\u2019 appearance of the healthy nigrosome - a new accurate test of Parkinson\u2019s disease: a case-control and retrospective cross-sectional MRI study at 3T. PLoS ONE 9(4):e93814\u2013e93814","journal-title":"PLoS ONE"},{"key":"4133_CR10","doi-asserted-by":"crossref","unstructured":"Huddleston DE et al (2018) Imaging Parkinsonian Pathology in Substantia Nigra with MRI. Curr Radiol Rep 6(4):5\u20137","DOI":"10.1007\/s40134-018-0272-x"},{"issue":"6","key":"4133_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11910-018-0841-7","volume":"18","author":"G Donatelli","year":"2018","unstructured":"Donatelli G et al (2018) Present and Future of Ultra-High Field MRI in Neurodegenerative Disorders. Curr Neurol Neurosci Rep 18(6):31","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"4133_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/mds.26932","volume":"32","author":"P Mahlknecht","year":"2017","unstructured":"Mahlknecht P et al (2017) Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson\u2019s disease. Mov Disord 32(4):619\u2013623","journal-title":"Mov Disord"},{"issue":"3","key":"4133_CR13","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1148\/radiol.14131448","volume":"271","author":"M Cosottini","year":"2014","unstructured":"Cosottini M et al (2014) MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease. Radiology 271(3):831\u2013838","journal-title":"Radiology"},{"issue":"1","key":"4133_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12883-017-0975-2","volume":"17","author":"MA Schmidt","year":"2017","unstructured":"Schmidt MA et al (2017) Ultra high-field SWI of the substantia nigra at 7T: reliability and consistency of the swallow-tail sign. BMC Neurol 17(1):194\u2013194","journal-title":"BMC Neurol"},{"issue":"3","key":"4133_CR15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1148\/radiol.212696","volume":"305","author":"M Brammerloh","year":"2022","unstructured":"Brammerloh M et al (2022) Swallow Tail Sign: Revisited. Radiology 305(3):674\u2013677","journal-title":"Radiology"},{"key":"4133_CR16","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.neuroimage.2017.11.035","volume":"172","author":"H Lee","year":"2018","unstructured":"Lee H et al (2018) Specific visualization of neuromelanin-iron complex and ferric iron in the human post-mortem substantia nigra using MR relaxometry at 7T. NeuroImage 172:874\u2013885","journal-title":"NeuroImage"},{"key":"4133_CR17","doi-asserted-by":"publisher","first-page":"118255","DOI":"10.1016\/j.neuroimage.2021.118255","volume":"239","author":"M Brammerloh","year":"2021","unstructured":"Brammerloh M et al (2021) Measuring the iron content of dopaminergic neurons in substantia nigra with MRI relaxometry. NeuroImage 239:118255","journal-title":"NeuroImage"},{"issue":"9","key":"4133_CR18","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3174\/ajnr.A5274","volume":"38","author":"S Shams","year":"2017","unstructured":"Shams S et al (2017) MRI of the Swallow Tail Sign: A Useful Marker in the Diagnosis of Lewy Body Dementia? AJNR. Am J Neuroradiol 38(9):1737\u20131741","journal-title":"Am J Neuroradiol"},{"issue":"2","key":"4133_CR19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/0284185120920793","volume":"62","author":"X Liu","year":"2021","unstructured":"Liu X et al (2021) Swallow tail sign on susceptibility map-weighted imaging (SMWI) for disease diagnosing and severity evaluating in parkinsonism. Acta Radiol 62(2):234\u2013242","journal-title":"Acta Radiol"},{"key":"4133_CR20","doi-asserted-by":"publisher","first-page":"102103","DOI":"10.1016\/j.nicl.2019.102103","volume":"25","author":"Z Cheng","year":"2020","unstructured":"Cheng Z et al (2020) Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson\u2019s disease. Neuroimage Clin 25:102103","journal-title":"Neuroimage Clin"},{"issue":"2","key":"4133_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/mdc3.14304","volume":"12","author":"VS Tseriotis","year":"2025","unstructured":"Tseriotis VS et al (2025) Is the Swallow Tail Sign a Useful Imaging Biomarker in Clinical Neurology? A Systematic Review. Mov Disord Clin Pract 12(2):134\u2013147","journal-title":"Mov Disord Clin Pract"},{"issue":"6","key":"4133_CR22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/jon.12775","volume":"30","author":"CE Weber","year":"2020","unstructured":"Weber CE et al (2020) Susceptibility-Weighted 3T MRI of the Swallow Tail Sign in Multiple Sclerosis: A Case Control Study. J Neuroimaging 30(6):766\u2013768","journal-title":"J Neuroimaging"},{"issue":"3","key":"4133_CR23","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s00415-021-10729-w","volume":"269","author":"MI Moreno-Gambin","year":"2022","unstructured":"Moreno-Gambin MI et al (2022) Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis. J Neurol 269(3):1631\u20131640","journal-title":"J Neurol"},{"issue":"3","key":"4133_CR24","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.neuroimage.2012.05.049","volume":"62","author":"C Langkammer","year":"2012","unstructured":"Langkammer C et al (2012) Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. NeuroImage 62(3):1593\u20131599","journal-title":"NeuroImage"},{"issue":"3","key":"4133_CR25","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.neuroimage.2011.08.077","volume":"59","author":"B Bilgic","year":"2012","unstructured":"Bilgic B et al (2012) MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. NeuroImage 59(3):2625\u20132635","journal-title":"NeuroImage"},{"key":"4133_CR26","doi-asserted-by":"publisher","first-page":"618435","DOI":"10.3389\/fnins.2021.618435","volume":"15","author":"P Ravanfar","year":"2021","unstructured":"Ravanfar P et al (2021) Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases. Front Neurosci 15:618435","journal-title":"Front Neurosci"},{"issue":"9","key":"4133_CR27","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.21037\/qims-21-87","volume":"11","author":"R Burgetova","year":"2021","unstructured":"Burgetova R et al (2021) Age-related magnetic susceptibility changes in deep grey matter and cerebral cortex of normal young and middle-aged adults depicted by whole brain analysis. Quant Imaging Med Surg 11(9):3906\u20133919","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"4133_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1148\/radiol.2522081399","volume":"252","author":"D Aquino","year":"2009","unstructured":"Aquino D et al (2009) Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 252(1):165\u2013172","journal-title":"Radiology"},{"issue":"2","key":"4133_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00234-020-02629-z","volume":"63","author":"BJ Burkett","year":"2021","unstructured":"Burkett BJ et al (2021) Clinical 7-T MRI for neuroradiology: strengths, weaknesses, and ongoing challenges. Neuroradiology 63(2):167\u2013177","journal-title":"Neuroradiology"},{"key":"4133_CR30","doi-asserted-by":"publisher","first-page":"102603","DOI":"10.1016\/j.pneurobio.2024.102603","volume":"236","author":"KE Stige","year":"2024","unstructured":"Stige KE et al (2024) The STRAT-PARK cohort: A personalized initiative to stratify Parkinson\u2019s disease. Prog Neurobiol 236:102603","journal-title":"Prog Neurobiol"},{"issue":"8","key":"4133_CR31","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","volume":"21","author":"A Charidimou","year":"2022","unstructured":"Charidimou A et al (2022) The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol 21(8):714\u2013725","journal-title":"Lancet Neurol"},{"issue":"12","key":"4133_CR32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"issue":"15","key":"4133_CR33","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129\u20132170","journal-title":"Mov Disord"},{"issue":"5","key":"4133_CR34","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"GT Stebbins","year":"2013","unstructured":"Stebbins GT et al (2013) How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: comparison with the unified Parkinson\u2019s disease rating scale. Mov Disord 28(5):668\u2013670","journal-title":"Mov Disord"},{"issue":"7","key":"4133_CR35","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mds.29410","volume":"38","author":"S.T. Jost","year":"2023","unstructured":"Jost ST, et al (2023) Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals. Mov Disord 38(7):1236\u20131252","journal-title":"Mov Disord"},{"key":"4133_CR36","unstructured":"Turner J Parkinson\u2019s Measurements. N.A. [cited 2021\u20132024; Available from: https:\/\/www.parkinsonsmeasurement.org\/toolBox\/levodopaEquivalentDose.htm"},{"issue":"6","key":"4133_CR37","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1002\/mrm.26963","volume":"79","author":"K Eckstein","year":"2018","unstructured":"Eckstein K et al (2018) Computationally Efficient Combination of Multi-channel Phase Data From Multi-echo Acquisitions (ASPIRE). Magn Reson Med 79(6):2996\u20133006","journal-title":"Magn Reson Med"},{"key":"4133_CR38","unstructured":"Graz NR .U.-M.U.o. Quantitative Susceptibility Mapping software. 15.01.25; Available from: neuroimaging. at\/pages\/qsm.php"},{"key":"4133_CR39","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.neuroimage.2015.02.041","volume":"111","author":"C Langkammer","year":"2015","unstructured":"Langkammer C et al (2015) Fast quantitative susceptibility mapping using 3D EPI and total generalized variation. NeuroImage 111:622\u2013630","journal-title":"NeuroImage"},{"issue":"3","key":"4133_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hbm.10062","volume":"17","author":"SM Smith","year":"2002","unstructured":"Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17(3):143\u2013155","journal-title":"Hum Brain Mapp"},{"key":"4133_CR41","doi-asserted-by":"publisher","first-page":"117358","DOI":"10.1016\/j.neuroimage.2020.117358","volume":"223","author":"C Rua","year":"2020","unstructured":"Rua C et al (2020) Multi-centre, multi-vendor reproducibility of 7T QSM and R(2)* in the human brain: Results from the UK7T study. NeuroImage 223:117358","journal-title":"NeuroImage"},{"issue":"5","key":"4133_CR42","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1002\/mrm.30006","volume":"91","author":"QSMCO Committee","year":"2024","unstructured":"Committee QSMCO et al (2024) Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: A consensus of the ISMRM electro-magnetic tissue properties study group. Magn Reson Med 91(5):1834\u20131862","journal-title":"Magn Reson Med"},{"issue":"1","key":"4133_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12874-018-0550-6","volume":"18","author":"CA Bobak","year":"2018","unstructured":"Bobak CA, Barr PJ, O\u2019Malley AJ (2018) Estimation of an inter-rater intra-class correlation coefficient that overcomes common assumption violations in the assessment of health measurement scales. BMC Med Res Methodol 18(1):93","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"4133_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med 15(2):155\u2013163","journal-title":"J Chiropr Med"},{"issue":"1","key":"4133_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159\u2013174","journal-title":"Biometrics"},{"issue":"4857","key":"4133_CR46","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1126\/science.3287615","volume":"240","author":"JA Swets","year":"1988","unstructured":"Swets JA (1988) Measuring the accuracy of diagnostic systems. Science 240(4857):1285\u20131293","journal-title":"Science"},{"issue":"1","key":"4133_CR47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ (1950) Index for rating diagnostic tests. Cancer 3(1):32\u201335","journal-title":"Cancer"},{"issue":"1","key":"4133_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jon.12576","volume":"29","author":"T Kau","year":"2019","unstructured":"Kau T et al (2019) Microvessels may Confound the Swallow Tail Sign in Normal Aged Midbrains: A Postmortem 7 T SW-MRI Study. J neuroimaging: official J Am Soc Neuroimaging 29(1):65\u201369","journal-title":"J neuroimaging: official J Am Soc Neuroimaging"},{"issue":"Pt 8","key":"4133_CR49","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier P et al (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain 122(Pt 8):1437\u20131448","journal-title":"Brain"},{"issue":"1","key":"4133_CR50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3988\/jcn.2018.14.1.90","volume":"14","author":"EY Kim","year":"2018","unstructured":"Kim EY et al (2018) Diagnosis of Early-Stage Idiopathic Parkinson\u2019s Disease Using High-Resolution Quantitative Susceptibility Mapping Combined with Histogram Analysis in the Substantia Nigra at 3 T. J Clin Neurol 14(1):90\u201397","journal-title":"J Clin Neurol"},{"issue":"1","key":"4133_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12868-019-0505-9","volume":"20","author":"Q Chen","year":"2019","unstructured":"Chen Q et al (2019) Iron deposition in Parkinson\u2019s disease by quantitative susceptibility mapping. BMC Neurosci 20(1):23","journal-title":"BMC Neurosci"},{"issue":"7","key":"4133_CR52","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/mds.27730","volume":"34","author":"N Bergsland","year":"2019","unstructured":"Bergsland N et al (2019) Ventral posterior substantia nigra iron increases over 3 years in Parkinson\u2019s disease. Mov Disord 34(7):1006\u20131013","journal-title":"Mov Disord"},{"issue":"1","key":"4133_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41531-025-00972-7","volume":"11","author":"CF Madelung","year":"2025","unstructured":"Madelung CF et al (2025) High-resolution mapping of substantia nigra in Parkinson\u2019s disease using 7 tesla magnetic resonance imaging. NPJ Parkinsons Dis 11(1):113","journal-title":"NPJ Parkinsons Dis"},{"issue":"10","key":"4133_CR54","doi-asserted-by":"publisher","first-page":"e0185489","DOI":"10.1371\/journal.pone.0185489","volume":"12","author":"C Gramsch","year":"2017","unstructured":"Gramsch C et al (2017) Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson\u2019s disease or merely an inconsistent, age-dependent imaging finding? PLoS ONE 12(10):e0185489","journal-title":"PLoS ONE"},{"key":"4133_CR55","doi-asserted-by":"publisher","first-page":"123383","DOI":"10.1016\/j.jns.2024.123383","volume":"469","author":"MT Chau","year":"2025","unstructured":"Chau MT et al (2025) Does age, sex, and area of substantia nigra echogenicity predict the MRI appearance of nigrosome-1? J Neurol Sci 469:123383","journal-title":"J Neurol Sci"},{"issue":"2","key":"4133_CR56","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1523\/JNEUROSCI.1907-15.2016","volume":"36","author":"J Acosta-Cabronero","year":"2016","unstructured":"Acosta-Cabronero J et al (2016) In Vivo MRI Mapping of Brain Iron Deposition across the Adult Lifespan. J Neurosci 36(2):364\u2013374","journal-title":"J Neurosci"},{"key":"4133_CR57","doi-asserted-by":"publisher","first-page":"607705","DOI":"10.3389\/fnins.2020.607705","volume":"14","author":"Y Li","year":"2020","unstructured":"Li Y et al (2020) Iron Content in Deep Gray Matter as a Function of Age Using Quantitative Susceptibility Mapping: A Multicenter Study. Front Neurosci 14:607705","journal-title":"Front Neurosci"},{"issue":"3","key":"4133_CR58","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/mds.29702","volume":"39","author":"GEC Thomas","year":"2024","unstructured":"Thomas GEC et al (2024) Longitudinal Associations of Magnetic Susceptibility with Clinical Severity in Parkinson\u2019s Disease. Mov Disord 39(3):546\u2013559","journal-title":"Mov Disord"},{"key":"4133_CR59","doi-asserted-by":"publisher","first-page":"111030","DOI":"10.1016\/j.ejrad.2023.111030","volume":"167","author":"M Chen","year":"2023","unstructured":"Chen M et al (2023) Free water and iron content in the substantia nigra at different stages of Parkinson\u2019s disease. Eur J Radiol 167:111030","journal-title":"Eur J Radiol"},{"issue":"5","key":"4133_CR60","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/00006231-200505000-00005","volume":"26","author":"L Filippi","year":"2005","unstructured":"Filippi L et al (2005) 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson\u2019s disease with unilateral symptoms. Nucl Med Commun 26(5):421\u2013426","journal-title":"Nucl Med Commun"},{"key":"4133_CR61","doi-asserted-by":"crossref","unstructured":"Palermo G et al (2021) Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review. Int J Mol Sci 22(20):11234","DOI":"10.3390\/ijms222011234"},{"issue":"2","key":"4133_CR62","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/mdc3.13091","volume":"8","author":"H Kathuria","year":"2021","unstructured":"Kathuria H et al (2021) Utility of Imaging of Nigrosome-1 on 3T MRI and Its Comparison with 18F-DOPA PET in the Diagnosis of Idiopathic Parkinson Disease and Atypical Parkinsonism. Mov Disord Clin Pract 8(2):224\u2013230","journal-title":"Mov Disord Clin Pract"},{"issue":"9","key":"4133_CR63","doi-asserted-by":"publisher","first-page":"e0162460","DOI":"10.1371\/journal.pone.0162460","volume":"11","author":"C Langkammer","year":"2016","unstructured":"Langkammer C et al (2016) Quantitative Susceptibility Mapping in Parkinson\u2019s Disease. PLoS ONE 11(9):e0162460","journal-title":"PLoS ONE"},{"key":"4133_CR64","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.neuroimage.2019.05.004","volume":"197","author":"M Lancione","year":"2019","unstructured":"Lancione M et al (2019) Echo-time dependency of quantitative susceptibility mapping reproducibility at different magnetic field strengths. NeuroImage 197:557\u2013564","journal-title":"NeuroImage"},{"issue":"1","key":"4133_CR65","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jon.12669","volume":"30","author":"P Spincemaille","year":"2020","unstructured":"Spincemaille P et al (2020) Quantitative Susceptibility Mapping: MRI at 7T versus 3T. J Neuroimaging 30(1):65\u201375","journal-title":"J Neuroimaging"},{"issue":"1","key":"4133_CR66","doi-asserted-by":"publisher","first-page":"e242044","DOI":"10.1148\/radiol.242044","volume":"317","author":"S Haller","year":"2025","unstructured":"Haller S et al (2025) Clinical MRI Biomarkers to Differentiate Parkinson Disease from Its Mimics. Radiology 317(1):e242044","journal-title":"Radiology"},{"key":"4133_CR67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-018-0047-3","volume":"4","author":"D Sulzer","year":"2018","unstructured":"Sulzer D et al (2018) Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson\u2019s disease. NPJ Parkinsons Dis 4:11","journal-title":"NPJ Parkinsons Dis"},{"issue":"6","key":"4133_CR68","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/jmri.29010","volume":"59","author":"Y Fushimi","year":"2024","unstructured":"Fushimi Y et al (2024) Value of Quantitative Susceptibility Mapping in Clinical Neuroradiology. J Magn Reson Imaging 59(6):1914\u20131929","journal-title":"J Magn Reson Imaging"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-026-04133-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-026-04133-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-026-04133-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:02:50Z","timestamp":1789455770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00234-026-04133-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4133"],"URL":"https:\/\/doi.org\/10.1007\/s00234-026-04133-2","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Norwegian regional committees for medical and health research ethics (REK) have approved the 7 Tesla study (REK 108066) and the STRAT-PARK cohort (REK 74985), and all participants have provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}